These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
281 related items for PubMed ID: 27611091
1. Underweight Is an Independent Risk Factor for Renal Function Deterioration in Patients with IgA Nephropathy. Ouyang Y, Xie J, Yang M, Zhang X, Ren H, Wang W, Chen N. PLoS One; 2016; 11(9):e0162044. PubMed ID: 27611091 [Abstract] [Full Text] [Related]
2. Association of high body mass index with development of interstitial fibrosis in patients with IgA nephropathy. Wu C, Wang AY, Li G, Wang L. BMC Nephrol; 2018 Dec 29; 19(1):381. PubMed ID: 30594167 [Abstract] [Full Text] [Related]
3. Clinical and prognostic significance of C1q deposition in IgAN patients-a retrospective study. Tian S, Yang X, Luo J, Guo H. Int Immunopharmacol; 2020 Nov 29; 88():106896. PubMed ID: 33182045 [Abstract] [Full Text] [Related]
4. Serum C3/C4 ratio is a novel predictor of renal prognosis in patients with IgA nephropathy: a retrospective study. Pan M, Zhou Q, Zheng S, You X, Li D, Zhang J, Chen C, Xu F, Li Z, Zhou Z, Zhang J. Immunol Res; 2018 Jun 29; 66(3):381-391. PubMed ID: 29850970 [Abstract] [Full Text] [Related]
5. Uric Acid as a Predictor of Immunoglobulin A Nephropathy Progression: A Cohort Study of 1965 Cases. Zhu B, Yu DR, Lv JC, Lin Y, Li Q, Yin JZ, Du YY, Tang XL, Mao LC, Li QF, Sun Y, Liu L, Li XF, Fei D, Wei XY, Zhu CF, Cheng XX, Chen HY, Wang YJ. Am J Nephrol; 2018 Jun 29; 48(2):127-136. PubMed ID: 30110674 [Abstract] [Full Text] [Related]
6. A validation study of crescents in predicting ESRD in patients with IgA nephropathy. Zhang X, Shi S, Ouyang Y, Yang M, Shi M, Pan X, Lv J, Wang Z, Ren H, Shen P, Wang W, Zhang H, Xie J, Chen N. J Transl Med; 2018 May 03; 16(1):115. PubMed ID: 29724226 [Abstract] [Full Text] [Related]
7. Impact of body mass index on progression of primary immunoglobulin a nephropathy. Nagaraju SP, Rangaswamy D, Mareddy AS, Prasad S, Kaza S, Shenoy S, Saraf K, Attur RP, Parthasarathy R, Kosuru S, Mateti UV, Guddattu V, Koulmane Laxminarayana SL. Saudi J Kidney Dis Transpl; 2018 May 03; 29(2):318-325. PubMed ID: 29657199 [Abstract] [Full Text] [Related]
8. Serum immunoglobulin G provides early risk prediction in immunoglobulin A nephropathy. Liu D, You J, Liu Y, Tang X, Tan X, Xia M, Wu L, Chen G, He L, Zhu X, Liu H. Int Immunopharmacol; 2019 Jan 03; 66():13-18. PubMed ID: 30415190 [Abstract] [Full Text] [Related]
9. Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients. Chai L, Cai K, Wang K, Luo Q. J Clin Lab Anal; 2021 Jun 03; 35(6):e23774. PubMed ID: 33951240 [Abstract] [Full Text] [Related]
10. Addition of eGFR and Age Improves the Prognostic Absolute Renal Risk-Model in 1,134 Norwegian Patients with IgA Nephropathy. Knoop T, Vågane AM, Vikse BE, Svarstad E, Magnúsdóttir BT, Leh S, Varberg Reisæter A, Bjørneklett R. Am J Nephrol; 2015 Jun 03; 41(3):210-9. PubMed ID: 25872002 [Abstract] [Full Text] [Related]
11. Association of obesity with the development of end stage renal disease in IgA nephropathy patients. Wang S, Qin A, Dong L, Tan J, Zhou X, Qin W. Front Endocrinol (Lausanne); 2023 Jun 03; 14():1094534. PubMed ID: 37020590 [Abstract] [Full Text] [Related]
12. Individuals of Pacific Asian origin with IgA nephropathy have an increased risk of progression to end-stage renal disease. Barbour SJ, Cattran DC, Kim SJ, Levin A, Wald R, Hladunewich MA, Reich HN. Kidney Int; 2013 Nov 03; 84(5):1017-24. PubMed ID: 23739233 [Abstract] [Full Text] [Related]
13. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population. Le W, Liang S, Hu Y, Deng K, Bao H, Zeng C, Liu Z. Nephrol Dial Transplant; 2012 Apr 03; 27(4):1479-85. PubMed ID: 21965586 [Abstract] [Full Text] [Related]
14. The Association of Low Hemoglobin Levels with IgA Nephropathy Progression: A Two-Center Cohort Study of 1,828 Cases. Zhu B, Liu WH, Yu DR, Lin Y, Li Q, Tong ML, Li YY, Yang RC, Du YY, Tang XL, Jiang F, Fei D, Wei XY, Zhang FF, Yin JZ, Wang WR, Li XF, Sun Y, Zhong YZ, Zhang MJ, Cheng XX, Zhu CF, Chen HY. Am J Nephrol; 2020 Apr 03; 51(8):624-634. PubMed ID: 32694247 [Abstract] [Full Text] [Related]
15. Risk factors of progressive IgA nephropathy which progress to end stage renal disease within ten years: a case-control study. Shu D, Xu F, Su Z, Zhang J, Chen C, Zhang J, Ding X, Lv Y, Lin H, Huang P. BMC Nephrol; 2017 Jan 07; 18(1):11. PubMed ID: 28061828 [Abstract] [Full Text] [Related]
16. Mesangial C4d deposition may predict progression of kidney disease in pediatric patients with IgA nephropathy. Fabiano RCG, de Almeida Araújo S, Bambirra EA, Oliveira EA, Simões E Silva AC, Pinheiro SVB. Pediatr Nephrol; 2017 Jul 07; 32(7):1211-1220. PubMed ID: 28233100 [Abstract] [Full Text] [Related]
17. Overweight and obesity accelerate the progression of IgA nephropathy: prognostic utility of a combination of BMI and histopathological parameters. Kataoka H, Ohara M, Shibui K, Sato M, Suzuki T, Amemiya N, Watanabe Y, Honda K, Mochizuki T, Nitta K. Clin Exp Nephrol; 2012 Oct 07; 16(5):706-12. PubMed ID: 22350469 [Abstract] [Full Text] [Related]
18. Cigarette smoking may accelerate the progression of IgA nephropathy. Wang S, Qin A, Pei G, Jiang Z, Dong L, Tan J, Tan L, Tang Y, Qin W. BMC Nephrol; 2021 Jun 29; 22(1):239. PubMed ID: 34187402 [Abstract] [Full Text] [Related]
19. Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy. Bazzi C, Rizza V, Casellato D, Stivali G, Rachele G, Napodano P, Olivieri G, Gallieni M, D'Amico G. J Nephrol; 2012 Jun 29; 25(5):810-8. PubMed ID: 22252844 [Abstract] [Full Text] [Related]
20. High Neutrophil-To-Lymphocyte Ratio Is an Independent Risk Factor for End Stage Renal Diseases in IgA Nephropathy. Wang S, Dong L, Pei G, Jiang Z, Qin A, Tan J, Tang Y, Qin W. Front Immunol; 2021 Jun 29; 12():700224. PubMed ID: 34456912 [Abstract] [Full Text] [Related] Page: [Next] [New Search]